Entellus Medical (ENTL) Tops Q2 EPS by 5c, Offers Q3 & FY Guidance

Entellus Medical (NASDAQ: ENTL) reported Q2 EPS of ($0.15), $0.05 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $15.2 million versus the consensus estimate of $15 million.

Entellus Medical sees FY2015 EPS of ($0.80)-($1.10), versus the consensus of ($0.98). Entellus Medical sees FY2015 revenue of $58.5-61 million, versus the consensus of $60.31 million.

Entellus Medical sees Q3 2015 EPS of ($0.20)-($0.28), versus the consensus of ($0.28). Entellus Medical sees Q3 2015 revenue of $13.9-14.4 million, versus the consensus of $14.12 million.

For earnings history and earnings-related data on Entellus Medical (ENTL) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SanDisk upgraded at JPMorgan after investor day; shares climb
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M